Genetic predisposition to adverse drug reactions in the intensive care unit.
about
Comparison of delivery strategies for pharmacogenetic testing servicesThe direct cost of care among surgical inpatients at a tertiary hospital in south west NigeriaDrug induced interstitial lung disease.Approaches for dosage individualisation in critically ill patients.Cis-stilbene glucoside in Polygonum multiflorum induces immunological idiosyncratic hepatotoxicity in LPS-treated rats by suppressing PPAR-γ.The pharmacogenomics of severe traumatic brain injury.Design and evaluation of a pharmacogenomics information resource for pharmacists.
P2860
Q26860925-EBE03F37-904B-45CF-B0A8-BA0663F45041Q34418614-6DC734CB-4ED0-4C5C-BB6D-F66DB738C579Q34641494-424C236E-3CB8-4BFF-B779-D7CDED9E4451Q38125209-FB57E0A6-A970-4A96-8440-DDB636AEE3DFQ38709657-980DB67A-24E9-4AE8-9A63-2C83CE46FE37Q48034526-66319FE0-1CBB-4A1C-AC25-04F3636E0800Q50775977-C3BA184F-1154-4FBF-A7AC-24C3C6C93386
P2860
Genetic predisposition to adverse drug reactions in the intensive care unit.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic predisposition to adverse drug reactions in the intensive care unit.
@en
Genetic predisposition to adverse drug reactions in the intensive care unit.
@nl
type
label
Genetic predisposition to adverse drug reactions in the intensive care unit.
@en
Genetic predisposition to adverse drug reactions in the intensive care unit.
@nl
prefLabel
Genetic predisposition to adverse drug reactions in the intensive care unit.
@en
Genetic predisposition to adverse drug reactions in the intensive care unit.
@nl
P1476
Genetic predisposition to adverse drug reactions in the intensive care unit.
@en
P2093
Philip E Empey
P304
P356
10.1097/CCM.0B013E3181DE09F8
P407
P433
P577
2010-06-01T00:00:00Z